Lu A-Lien, Lee Chih-Yung, Li Lina, Li Xianghong
Department of Biochemistry and Molecular Biology and Greenebaum Cancer Center, School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Biochem J. 2006 Jan 1;393(Pt 1):381-7. doi: 10.1042/BJ20051133.
Both GO (7,8-dihydro-8-oxoguanine) and hoU (5-hydroxyuracil) are highly mutagenic because DNA polymerase frequently misincorporates adenine opposite these damaged bases. In Escherichia coli, MutY DNA glycosylase can remove misincorporated adenine opposite G or GO on the template strand during DNA replication. MutY remains bound to the product that contains an AP (apurinic/apyrimidinic) site. Endo VIII (endonuclease VIII) can remove oxidized pyrimidine and weakly remove GO by its DNA glycosylase and beta/delta-elimination activities. In the present paper, we demonstrate that Endo VIII can promote MutY dissociation from AP/G, but not from AP/GO, and can promote beta/delta-elimination on the products of MutY. MutY interacts physically with Endo VIII through its C-terminal domain. MutY has a moderate affinity for DNA containing a hoU/A mismatch, which is a substrate of Endo VIII. MutY competes with Endo VIII and inhibits Endo VIII activity on DNA that contains a hoU/A mismatch. Moreover, MutY has a weak adenine glycosylase activity on hoU/A mismatches. These results suggest that MutY may have some role in reducing the mutagenic effects of hoU.
8-氧代鸟嘌呤(GO,7,8-二氢-8-氧代鸟嘌呤)和5-羟基尿嘧啶(hoU)都具有高度致突变性,因为DNA聚合酶在这些受损碱基对面经常错误掺入腺嘌呤。在大肠杆菌中,MutY DNA糖基化酶可在DNA复制过程中去除模板链上与G或GO相对的错误掺入的腺嘌呤。MutY会与含有脱嘌呤/脱嘧啶(AP)位点的产物结合。核酸内切酶VIII(Endo VIII)可通过其DNA糖基化酶和β/δ消除活性去除氧化的嘧啶并微弱地去除GO。在本文中,我们证明Endo VIII可促进MutY从AP/G而非AP/GO上解离,并可促进MutY产物上的β/δ消除。MutY通过其C端结构域与Endo VIII发生物理相互作用。MutY对含有hoU/A错配的DNA具有中等亲和力,而hoU/A错配是Endo VIII的底物。MutY与Endo VIII竞争,并抑制Endo VIII对含有hoU/A错配的DNA的活性。此外,MutY对hoU/A错配具有较弱的腺嘌呤糖基化酶活性。这些结果表明,MutY可能在降低hoU的致突变作用中发挥一定作用。